Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug

NYT HEALTH: Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug
By Rebecca Robbins and Reed Abelson
Section: Health
Source: New York Times
Published Date: May 11, 2025 at 03:00AM

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed by insurance that disrupt treatments for patients.

Read more: https://www.nytimes.com/2025/05/11/health/zepbound-wegovy-weight-loss-drugs.html?partner=IFTTT